Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic

Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic

Although the introduction of stem cell transplantation and novel agents has improved survival, multiple myeloma (MM) is still difficult to cure. Alternative approaches are clearly needed to prolong the survival of patients with MM. Dendritic cell (DC) therapy is a very promising tool immunologically...

Full description

Bibliographic Details
Main Authors: Hoang, My-Dung, Jung, Sung-Hoon, Lee, Hyun-Ju, Lee, Youn-Kyung, Nguyen-Pham, Thanh-Nhan, Choi, Nu-Ri, Vo, Manh-Cuong, Lee, Seung-Shin, Ahn, Jae-Sook, Yang, Deok-Hwan, Kim, Yeo-Kyeoung, Kim, Hyeoung-Joon, Lee, Je-Jung
Format: Online
Language:English
Published: Chonnam National University Medical School 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406989/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406989/

Similar Items